By The Online Investor Staff, updated Wed., Oct. 22, 11:23 AM
Slide #1. Atara Biotherapeutics, Inc. — Initial Public Offering
||Atara Biotherapeutics, Inc.
|Price Per Share:
||Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a drug development company with a focus on innovative therapies for patients with debilitating diseases, today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $11.00 per share, before underwriting discounts and commissions. The shares are expected to begin trading on The NASDAQ Global Select Market under the ticker symbol "ATRA" on October 16, 2014. In addition, Atara has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock from Atara at the initial public offering price to cover over-allotments, if any. The offering is expected to close on October 21, 2014, subject to customary closing conditions.
IPOs: Atara Biotherapeutics, Inc.
List of IPOs in this Slideshow:
Company Ticker IPO Date
Great Western Bancorp, Inc. GWB
Fairmount Santrol FMSA
Dominion Midstream Partners, LP DM
Zayo Group Holdings, Inc. ZAYO
Eagle Point Credit Company Inc. ECC
Great Basin Scientific, Inc., DBA Great Basin CorporationGBSN
MOL Global Inc. MOLG
Intercorp Financial Services Inc. T.B.D.
Veritex Holdings, Inc. VBTX
Electronic Cigarettes International GroupECIG
Anchor Bancorp Wisconsin Inc ABCW
Ocean Rig Partners LP T.B.D.
The Joint Corp. JYNT
The Habit Restaurants, Inc. T.B.D.
Atara Biotherapeutics, Inc. ATRA
October 22, 2014 11:23 AM Eastern